RT Journal Article
SR Electronic
T1 Risk factors of reintubation in patients receiving post-extubation nasal high flow therapy
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP 3447
DO 10.1183/13993003.congress-2020.3447
VO 56
IS suppl 64
A1 Min Ju Jo
A1 Yun Jung Huh
A1 Yoomi Yeo
A1 Ji-Yong Moon
A1 Tae-Hyung Kim
A1 Sung Jun Chung
A1 Hyun Lee
A1 Dong Won Park
A1 Sang Heon Kim
A1 Jang Won Sohn
A1 Ho Joo Yoon
A1 Tai Sun Park
YR 2020
UL http://erj.ersjournals.com/content/56/suppl_64/3447.abstract
AB Background: Use of nasal high-low therapy (NHF) after extubation was known to lower reintubation rate. However, there are still patients undergoing reintubation despite of post-extubation NHF therapy.Objectives: The purpose of this study was to evaluate the risk factors of reintubation in patients receiving post-extubation NHF therapy.Methods: From January 2018 to June 2019, patients who underwent mechanical ventilation and NHF after extubation at Hanyang University Guri Hospital were analyzed retrospectively. All patients received adequate sedation and planned extubation was performed after passing spontaneous awakening test and spontaneous breathing test (SBT).Result: Total 65 patients were enrolled, mean age of the 65 patients was 71.0 [55.0;76.0] years, two thirds of patients were male and mean body mass index was 23.1 [21.1;26.0]. 10 (15.4%) patients were reintubated duration of ICU stay, which mean period was 6 days. As analyzed between reintubated Vs. non-reintubated group, there was no significant differenced between two groups in not only baseline characteristics but also use of medication or SBT duration. In clinical outcomes, duration of ICU stay in reintubated patients was significant longer, 19.0 [11.0;25.0] days (5.0 [ 4.0; 9.0] days in non-reintubated patients, p < 0.001). However, both in univariate and multivariate analysis, we cannot find significant prognostic factor.Conclusion: This was the preliminary study, there was no significant factor between two groups in prognosis. Further evaluation of risk factors of reintubation should be studied in future.FootnotesCite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 3447.This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).